Onyx Seeks Suitors After Rejecting Amgen’s Bid

July 1 (Bloomberg) -- Onyx Pharmaceuticals, the maker of the cancer drug Nexavar, said it is in contact with other possible acquirers after rejecting an unsolicited $120-a-share cash takeover bid from Amgen Onyx shares surged. Dominic Chu reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Maybe Zuckerberg Should Listen to These Canadian Hipsters
26:34 - Maybe Mark Zuckerberg should take a cue from the Canadian hipsters who created the Bunz Trading Zone. Centered on Toronto, the invite-only Facebook group has become a gathering place for the downtown crowd to barter goods and services. Much of the inventory is what you’d expect young urbanites to trade -- furniture, books, massages -- although there’s weirder stuff, too, including human teeth, second-hand sex toys and, um, dreadlocks. Bloomberg's Gerrit De Vynck reports. (Source: Bloomberg)
  • UBS's Emanuel: I See Oil at $70 by End of 2018
  • Wine Output Near 20-Year Low as Rain, Frost Hit Vineyards
  • 8,000-Mile Journey Spurs Vale Shift as Iron Outlook Fades